Plasma immunoreactive relaxin levels in pregnant and nonpregnant women. 1978

E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz

Immunoreactive relaxin was measured in plasma samples obtained from human volunteers utilizing the RIA procedure of Sherwood et al., as modified by O'Byrne and Steinetz for heterologous plasma samples. Immunoreactive hormone was not detected in samples obtained from men, and only rarely in plasma of nonpregnant women. Immunoreactive relaxin was present as early as the fourth week of pregnancy and was detectable throughout the course of gestation. Immunoreactive relaxin tended to be higher early in pregnancy, and there was no peak just before parturition as occurs in many other species. Our results are at variance with those of Bryant and coworkers, who reported high levels of immunoreactive relaxin in men and nonpregnant as well as pregnant women. The possible reasons for this discrepancy are presented.

UI MeSH Term Description Entries
D007743 Labor, Obstetric The repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix (CERVIX UTERI). Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced (LABOR, INDUCED). Obstetric Labor
D008297 Male Males
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D008656 Mestranol The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy-, (17alpha)-,Ethinyl Estradiol 3-Methyl Ether,Ethinyl Estradiol 3 Methyl Ether
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012065 Relaxin A water-soluble polypeptide (molecular weight approximately 8,000) extractable from the corpus luteum of pregnancy. It produces relaxation of the pubic symphysis and dilation of the uterine cervix in certain animal species. Its role in the human pregnant female is uncertain. (Dorland, 28th ed) Relaxin B
D003277 Contraceptives, Oral, Combined Fixed drug combinations administered orally for contraceptive purposes. Combined Oral Contraceptive,Contraceptive Agents, Female, Combined,Oral Contraceptives, Combined,Combined Oral Contraceptives,Contraceptive, Combined Oral,Contraceptives, Combined Oral,Oral Contraceptive, Combined
D005260 Female Females

Related Publications

E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
November 1975, Clinica chimica acta; international journal of clinical chemistry,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
October 1987, Biology of reproduction,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
September 1983, The Journal of clinical endocrinology and metabolism,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
January 1990, Comparative biochemistry and physiology. A, Comparative physiology,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
January 1959, Annals of the New York Academy of Sciences,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
November 2000, Free radical research,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
September 1986, Anesthesia and analgesia,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
August 1957, Obstetrics and gynecology,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
January 1986, Biological research in pregnancy and perinatology,
E M O'Byrne, and B T Carriere, and L Sorensen, and A Segaloff, and C Schwabe, and B G Steinetz
January 1989, International journal of fertility,
Copied contents to your clipboard!